Skip to content

Looking for novel treatments for autosomal dominant polycystic kidney disease

Looking for novel treatments for autosomal dominant polycystic kidney disease 25 June 2022 We are delighted to fund Professor Colin A Johnson and his work looking for novel treatments for autosomal dominant polycystic kidney disease (ADPKD).    The problem ADPKD is a genetic disorder that leads to fluid filled sacs (cysts) forming in the kidneys. It…

Read More

Testing new treatments for autosomal dominant polycystic kidney disease

Testing new treatments for autosomal dominant polycystic kidney disease 24 June 2022 It is with great pleasure we announce that we are funding Professor Albert Ong, from the University of Sheffield, on his mission to discover and test new treatments for autosomal dominant polycystic kidney disease (ADPKD).   The problem Autosomal dominant polycystic kidney disease…

Read More

PKD PhD Studentship for Dr Joe Cockburn

PKD PhD Studentship for Dr Joe Cockburn 23 June 2022 We are thrilled to fund a PhD student to work on this project under the supervision of Dr Joe Cockburn. Joe will lead a journey of discovery through faults in the PKHD1 gene and will learn more about the impact they have on the developing…

Read More

New treatment recommended for kidney patients with anaemia

New treatment recommended for kidney patients with anaemia 21 June 2022 The National Institute for Health and Care Excellence (NICE) has recommended roxadustat for the treatment of anaemia in adult chronic kidney disease (CKD) patients. The new first of its kind medication (brand name Evrenzo) will offer a simplified and more tolerable treatment. The exciting…

Read More

NICE decision brings transplant hope to highly sensitised patients

NICE decision brings transplant hope to highly sensitised patients 17 June 2022 Kidney Research UK has welcomed a decision by the National Institute for Health and Care Excellence to recommend a treatment to enable people who are highly sensitised to have a kidney transplant without the organ being rejected. What is imlifidase? The new treatment,…

Read More

‘Gold standard’ research hub gets to work after Manchester launch

‘Gold standard’ research hub gets to work after Manchester launch 16 June 2022 A new research hub dedicated to the study of Alport syndrome has been launched at the University of Manchester. The Stoneygate and Kidney Research UK Alport Research Hub, was created thanks to £2.55M investment from Stoneygate Trust in partnership with charity Kidney…

Read More

Identifying who will develop diabetes after kidney transplant

Identifying who will develop diabetes after kidney transplant 09 June 2022 Professor Amy Jayne McKnight, from Queen’s University Belfast, has been awarded a Stoneygate research project grant to study who is at higher risk of developing diabetes after receiving a kidney transplant. Developing diabetes post transplant New onset diabetes after transplant is a serious complication…

Read More

How do excessive blood clots form in ANCA associated vasculitis?

How do excessive blood clots form in ANCA associated vasculitis? 07 June 2022 We have awarded Dr Tom Mckinnon from Imperial College London a grant to recruit a PhD student to investigate how AAV causes excessive clotting. What is antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis? Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease where…

Read More

My son Joseph is still waiting for a transplant

My son Joseph is still waiting for a transplant Blog post by Sara Turkentine 06 June 2022 I recently wrote to supporters of Kidney Research UK and shared my family’s story. I’m Sara, and my husband’s name is Matt. If you received the letter with our story in, you might remember that we were getting…

Read More
Scroll To Top